Electrospun Polymer Nanofiber Coatings for Implantable Medical Devices
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preventing infections in implanted medical devices, such as prosthetic joints and cardiac implantable electrophysiological devices, are inadequate due to the formation of biofilms that protect bacteria from antibiotics, leading to chronic and persistent infections, and existing solutions do not effectively combine antibacterial efficiency with osseointegration.
Innovation Solution
A nanofiber-based conformal coating is developed using electrospinning to deposit polymer nanofibers with embedded antibiotics, allowing for controlled and independent local delivery of multiple antimicrobial agents, preventing biofilm formation by releasing antibiotics simultaneously at different rates to maintain effective antimicrobial activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If perioperative prophylactic systemic antibiotics are used, then infection prevention is attempted, but the rate of deep infection remains as high as 1-4% due to biofilm formation
Solution Approach 1:
The patent applies preliminary action by coating the implantable medical device with antimicrobial agents before implantation. The device surface is pre-treated with antibiotics or antimicrobial peptides that remain active during implantation, preventing initial bacterial adhesion and biofilm formation before the infection can establish itself.
Solution Approach 2:
The patent implements local quality by concentrating antimicrobial agents directly at the implant surface where bacteria would initially adhere. This localized high-concentration delivery system ensures that the implant surface itself has inherent antimicrobial properties, creating a protective barrier exactly where needed rather than relying on systemic circulation.
2Reliability
If antimicrobial therapy is used, then bacterial infection is treated, but the therapy is unsuccessful unless the biofilm is physically disrupted by surgical debridement
Solution Approach 1:
The patent prevents the need for surgical debridement by applying antimicrobial protection preliminarily during implantation. The pre-coated device prevents biofilm formation from occurring in the first place, eliminating the need for later surgical disruption and prolonged antibiotic therapy.
Solution Approach 2:
The patent applies preliminary anti-action by pre-equipping the implant surface with antimicrobial agents that actively counteract bacterial adhesion before it can occur. This preemptive approach neutralizes the threat of biofilm formation, making subsequent surgical intervention unnecessary.
3Adaptability or versatility
If a conformal coating with multiple antimicrobial agents is deposited using electrospinning, then controlled and independent local delivery of multiple antimicrobial agents is achieved, but the coating process requires precise temperature control during annealing
Solution Approach 1:
The patent utilizes parameter changes by carefully controlling the annealing temperature to be above the melting point of the first polymer but below the degradation temperature of the antimicrobial agents. This precise parameter control enables the phase transition of the polymer matrix for drug release while preserving the integrity and activity of the embedded antimicrobial compounds.
Solution Approach 2:
The patent employs composite materials by creating a multi-component electrospun coating system consisting of different polymers with distinct melting temperatures and multiple antimicrobial agents. This composite structure allows each component to contribute specific properties: one polymer provides structural integrity while another enables controlled release, and multiple antimicrobial agents provide synergistic protection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The coating composition effectively prevents biofilm-associated infections by maintaining sustained antibiotic release, reducing bacterial burden, and promoting osseointegration, thereby enhancing the longevity and performance of implanted medical devices.
Implementation Method 1
depositing onto at least a portion of a metallic surface of an implantable medical device using electrospinning: (i) a plurality of polymer nanofibers
Implementation Method 2
annealing the implantable medical device for a controlled time period at a controlled temperature that is higher than the melting temperature of the first set of polymer nanofibers
Implementation Method 3
a plurality of polymer nanofibers, wherein the plurality of polymer nanofibers comprise at least a first set of polymer nanofibers with a melting temperature of about 40° C. to about 100° C.
Implementation Method 4
cooling the implantable device to form a solid coating comprising the plurality of polymer nanofibers and the first bioactive agent
Data Source
AI summary
The presently disclosed subject matter provides a coating composition which allows for the co-delivery of two or more bioactive agents with independent control of loading level and release profile for each bioactive agent, an implantable medical device coated with the coating composition, and methods for preparing the coating composition.